Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Aug 03, 2026
SpaceX (SPCX) Stock Slides -34% Over 30 Days as Lockup and Earnings Loom

SpaceX (SPCX) Stock Slides -34% Over 30 Days as Lockup and Earnings Loom

Key Takeaways

  • SpaceX (SPCX) shares have declined approximately 34% over the past 30 days, falling from $162.00 on July 2 to around $106.33 as of early August, and are now trading well below the June IPO price of $135.
  • The stock's all-time high of $225.64, reached on June 16, has given way to a sustained sell-off that has erased over $1 trillion in market capitalization from peak levels.
  • Massive short interest — estimated at 29% to 56% of the free float — has amplified downward pressure, with short sellers sitting on billions in paper profits since the IPO.
  • A major lockup expiration on August 6 could free up to 911.5 million insider shares for trading, roughly tripling the current public float and creating a potential supply overhang.
  • The company's first-ever quarterly earnings report as a public company, due August 4, represents a critical catalyst that will test whether SpaceX's high-growth narrative can justify its premium valuation.

SpaceX Company Overview and Market Position

Space Exploration Technologies Corp. — widely known as SpaceX — designs, manufactures, and launches advanced rockets and spacecraft. Founded in 2002 by Elon Musk, the company operates three core business segments: space launch services through its Falcon and Starship rocket families, satellite-based broadband connectivity via its Starlink constellation serving over 10 million subscribers across 164 countries, and an artificial intelligence division built around the xAI acquisition completed in early 2026. SpaceX completed the largest IPO in history on June 12, 2026, raising approximately $75 billion at $135 per share. The company's unique vertical integration — controlling launch, satellite deployment, broadband delivery, and AI infrastructure under one roof — positions it as a dominant force across aerospace, telecommunications, and emerging AI computing markets. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

SpaceX Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, SPCX has fallen from a closing price of $162.00 on July 2 to approximately $106.33 in early August — a decline of roughly 34%. The stock broke decisively below its $135 IPO price in mid-July and has continued sliding, establishing a series of lower lows. For the broader quarter — which essentially covers SpaceX's entire seven-week trading history since its June 12 market debut — the stock has declined approximately 21% from its IPO price and roughly 47% from its post-listing intraday peak of $225.64. The initial euphoria that propelled SPCX to a valuation exceeding $2.6 trillion has been replaced by deepening investor scrutiny of the company's profitability path, capital requirements, and near-term share supply dynamics.

What Drove SPCX Stock Price in the Last 30 Days

Several converging forces fueled the sharp 30-day decline. The Starship Flight 13 launch abort on July 16 — when four Raptor engines failed to ignite seconds before liftoff — rattled confidence in the company's execution timeline, sending shares below the IPO price for the first time. Although a successful relaunch on July 24 achieved key milestones including the first deployment of Starlink V3 satellites and an in-space engine relight, the stock failed to recover. Broader market rotation away from high-valuation, capital-intensive technology names compounded the pressure, as investors reassessed AI infrastructure spending returns following concerns raised across the semiconductor and cloud computing sectors. Short sellers aggressively increased their positions, with bearish bets reportedly reaching 34% to 56% of the tradable float — one of the largest short positions in the market. SpaceX's late-June $25 billion bond offering, while bolstering liquidity, reminded investors of the company's substantial debt load and the cost of its AI ambitions. Additionally, the imminent August 6 lockup expiration — allowing early investors and employees to sell up to 911.5 million restricted shares — created a formidable supply overhang. Finally, the company's Q2 earnings report on August 4 looms as the first public test of whether Starlink's profitability and AI revenue growth can offset massive capital expenditures that reached $10.1 billion in Q1 alone. I reviewed recent signals on this using Tickeron’s AI Daily Buy/Sell Signals to get additional context.

What Drove SPCX Stock Performance Over the Last Quarter

Since going public on June 12, SpaceX's stock has traced a dramatic arc from euphoria to deep correction. The IPO priced at $135 and opened at $150, surging to $225.64 within days as retail and institutional investors clamored for a piece of one of the world's most ambitious technology companies. Index inclusion — SPCX was added to the Nasdaq-100 on July 7 — provided an initial demand boost. However, the extreme post-IPO valuation, which at its peak implied a price-to-sales ratio approaching 140x, proved unsustainable as investors shifted focus from narrative to fundamentals. The company's 2025 net loss of $4.9 billion and Q1 2026 net loss of $4.28 billion underscored the gap between ambition and profitability. Starlink, the company's earnings engine, generated $11.4 billion in 2025 revenue with strong margins, but AI-related operating losses of $2.5 billion in Q1 and capital expenditures of $7.7 billion for the AI segment alone raised legitimate questions about the timeline for consolidated profitability. The quarter also featured the acquisition of Anysphere (maker of the Cursor AI coding assistant) for approximately $60 billion in stock, further fueling dilution concerns. Analyst price targets remain bullish — the consensus 12-month target sits near $236 — but a market now pricing for execution risk rather than blue-sky potential has driven the stock materially lower.

SPCX Stock Forecast Drivers: What Investors Should Watch Next

The August 4 Q2 earnings release is the single most important near-term event for SPCX shareholders. Consensus estimates call for revenue of approximately $6.9 billion and an adjusted loss of $0.23 to $0.26 per share, but investors will focus heavily on segment-level profitability, AI revenue ramp, Starlink subscriber growth and average revenue per user trends, and forward capital expenditure guidance. The August 6 lockup expiration represents a critical supply event — even partial insider selling could exert meaningful pressure on a stock with a limited float. Longer term, Starship's path to full reusability and orbital certification will determine whether SpaceX can deploy its next-generation V3 Starlink satellites at scale and pursue orbital data center ambitions. Macroeconomic factors including interest rate policy, AI sector sentiment, and government space and defense contracting will also shape the investment landscape. With short interest at historically elevated levels, any positive catalyst — stronger-than-expected earnings, upbeat guidance, or a major contract announcement — could trigger a rapid short-covering rally, adding to the stock's already pronounced volatility.

AI Trading Bots for Volatile Names

I often turn to Tickeron’s AI Trading Bots when analyzing high-volatility stocks like this one. The platform’s automated strategies provide real-time performance data, historical metrics, and risk profiles across different holding periods, helping me evaluate approaches that align with current market conditions without needing to sift through everything manually. For names with elevated short interest and upcoming catalysts, these tools offer a structured way to review potential signals alongside traditional research.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SPCX

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 38.94B. The market cap for tickers in the group ranges from 4.49 to 1.92T. SPCX holds the highest valuation in this group at 1.92T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -1%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -11%. SPCX experienced the highest price growth at 18%, while PUSA experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 19%. For the same stocks of the Industry, the average monthly volume growth was 41% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 45
P/E Growth Rating: 70
Price Growth Rating: 62
SMR Rating: 77
Profit Risk Rating: 76
Seasonality Score: 14 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Industry
N/A
Address
1 Rocket Road
Phone
+1 310 363-6000
Employees
22000
Web
https://www.spacex.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.
I've always appreciated how Mastercard (MA) maintains a commanding position in the global payments industry, processing transactions across 3.4 billion cards at 150 million merchant locations worldwide. The network effects here create a formidable moat—increased adoption by issuers, acquirers, and consumers just reinforces its dominance. What stands out to me is how Mastercard is evolving beyond a pure processor into a services-first platform. Value-added services (VAS)—covering cybersecurity, data analytics, and consulting—are now approaching 40% of revenues and growing at double the rate of traditional payments.
MU shares are declining approximately -6.00% in premarket trading on April 2, 2026, pulling back to roughly $353.70 from the prior session's close of $376.27. The primary catalyst is a sweeping new round of tariff announcements from the Trump administration, dubbed by markets as "Liberation Day 2.0," which has sparked a broad risk-off selloff across technology and semiconductor stocks
Shares of Robinhood Markets are down approximately 6.15% in Thursday's intraday session, trading around $65.80 after closing at $70.11 on April 1, 2026. Wolfe Research delivered a sharp blow by cutting its price target on HOOD by 30%, citing persistent weakness in crypto trading volumes as a core drag on revenue.